128 related articles for article (PubMed ID: 74637)
1. Clioquinol toxicity.
Worden AN; Heywood R
Lancet; 1978 Jan; 1(8057):212. PubMed ID: 74637
[No Abstract] [Full Text] [Related]
2. [Further study on the neurotoxicity of clioquinol in beagle dogs (author's transl)].
Tateishi J; Kuroda S; Ikeda H
Seishin Shinkeigaku Zasshi; 1975 May; 77(5):378-82. PubMed ID: 144926
[No Abstract] [Full Text] [Related]
3. Comparative study of neurotoxicity of clioquinol, ethambutol, isoniazid and chloramphenicol in dogs.
Tateishi J
Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):11-7. PubMed ID: 4275984
[No Abstract] [Full Text] [Related]
4. [Neurotoxicity of chinoform].
Tateishi J
Fukuoka Igaku Zasshi; 1976 Mar; 67(3):75-81. PubMed ID: 133072
[No Abstract] [Full Text] [Related]
5. Neurotoxicity of clioquinol in laboratory animals.
Tateishi J; Kuroda S; Saito A; Otsuki S
Lancet; 1972 Nov; 2(7786):1095. PubMed ID: 4117427
[No Abstract] [Full Text] [Related]
6. [Experimental studies of influence of hepatic insufficiency on pathogenesis of S.M.O.N. (subacute myelo-optico neuropathy) caused by chinoform administration in dogs (author's transl)].
Hayakawa K
Hokkaido Igaku Zasshi; 1974 May; 49(3):213-23. PubMed ID: 4281757
[No Abstract] [Full Text] [Related]
7. Experimental reproduction of SMON in animals by prolonged administration of clioquinol: clinico-pathological findings.
Tateishi J; Otsuki S
Jpn J Med Sci Biol; 1975; 28 Suppl():165-86. PubMed ID: 136536
[No Abstract] [Full Text] [Related]
8. Toxicity of oxyquinolines.
Hansson O
Lancet; 1977 May; 1(8022):1152. PubMed ID: 68247
[No Abstract] [Full Text] [Related]
9. Idiosyncratic neurotoxicity: clioquinol and bismuth.
Lancet; 1980 Apr; 1(8173):857-8. PubMed ID: 6103216
[No Abstract] [Full Text] [Related]
10. Relationship between neurological symptoms and concentrations of clioquinol in serum and nervous systems of beagle dogs.
Hayakawa K; Imanari T; Tamura Z; Kuroda S; Ikeda H; Tateishi J
Chem Pharm Bull (Tokyo); 1977 Aug; 25(8):2013-8. PubMed ID: 144569
[No Abstract] [Full Text] [Related]
11. Experimental studies utilizing radionuclide-labelled clioquinol as tracer in vivo.
Toyokura Y; Takasu T; Matsuoka O
Jpn J Med Sci Biol; 1975; 28 Suppl():79-86. PubMed ID: 136543
[No Abstract] [Full Text] [Related]
12. Clinical chemistry of clioquinol.
Tamura Z
Jpn J Med Sci Biol; 1975; 28 Suppl():69-77. PubMed ID: 136542
[No Abstract] [Full Text] [Related]
13. Effects of metal-containing drugs taken simultaneously with clioquinol upon clinical features of SMON.
Okada H; Aoki K; Ohno Y; Kitazawa S; Ohtani M
J Toxicol Sci; 1984 Nov; 9(4):327-41. PubMed ID: 6241266
[TBL] [Abstract][Full Text] [Related]
14. S.M.O.N.
Spillane JD
Lancet; 1972 Jan; 1(7742):154. PubMed ID: 4109013
[No Abstract] [Full Text] [Related]
15. Subacute myelo-optic neuropathy in Australia.
Selby G
Lancet; 1972 Jan; 1(7742):123-5. PubMed ID: 4108984
[No Abstract] [Full Text] [Related]
16. Subacute myelo-optic neuropathy. A toxic or a viral etiology?
Otte G; De Coster W; Thiery E; De Reuck J; Vander eecken H
Acta Neurol Belg; 1976; 76(5-6):331-4. PubMed ID: 137650
[TBL] [Abstract][Full Text] [Related]
17. Subacute myelo-optico-neuropathy (SMON) and clioquinol: -A response to doubts about clioquinol causation theory-.
Shigematsu I
Jpn J Med Sci Biol; 1975; 28 Suppl():35-55. PubMed ID: 136540
[No Abstract] [Full Text] [Related]
18. [Subacute myelo-optic neuritis].
Vanĕcek J; Fink Z
Cesk Pediatr; 1979 Nov; 34(11):661-2. PubMed ID: 160840
[No Abstract] [Full Text] [Related]
19. [Subacute myelopathy during a course of treatment with clioquinol in a patient colectomized for Crohn's disease].
Fabiani F; Pompili A; Scarinci A; Sinibaldi L
Riv Neurobiol; 1978; 24(1-2):121-37. PubMed ID: 161413
[No Abstract] [Full Text] [Related]
20. Data on clioquinol and S.M.O.N.
Lee JA
Lancet; 1978 Sep; 2(8092 Pt 1):738. PubMed ID: 80663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
